Shares of Intuitive Surgical (NASDAQ:ISRG) closed higher 3.63 percent higher on Monday, one day before the company is to release its fiscal third-quarter earnings report. The jump is attributable in part to JPMorgan upgrading Intuitive Surgical’s stock to Outperform.
The upgrade came in spite of a recent downturn in domestic prostate surgeries, which the firm believes can be more than made up for by increased opportunities in other cancer areas.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
“We find the risk/reward increasingly compelling, in light of the meaningful opportunities emerging in partial nephrectomy, cholecystectomy, colorectal surgery, and other areas – which, collectively, should more than offset the [prostate surgery] softness and drive upside to Street estimates for the next several years,” said JPMorgan analyst Tycho Peterson.
The firm raised earnings per share estimates for the 2012 fiscal year to $14.85 per share, up from $11.57. Intuitive Surgical’s third quarter earnings will be released on Tuesday.
Don’t Miss: Abbott Labs Pops to New All-Time High After Clinical Results.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more